OrganiGram Holdings Inc.
TSX:OGI.TODrug Manufacturers - Specialty & Generic
-$0.02 today
- Market cap
- $135.37M
- Beta
- 1.84
- P/E (TTM)
- -7.2
- EPS (TTM)
- -$0.19
Volume 0.54M
Average 0.19M
OGI.TO Net Income
Bottom-line profit, the starting point for calculating cash from operations.
OrganiGram Holdings Inc.TSX: OGI.TO
Net Income · Q2 FY2026 · quarter ended Mar 2026
Net income turns negative
Q2 FY2026 net income was -CA$921K, compared with CA$42.46M a year earlier. Trailing-twelve-month net income was -CA$25.21M.
Context
- Net income amounted to 9.6% of revenue in FY2025, down 18.9 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of CA$104.54M (+522.2%) for the fiscal year ending Sep 2026, a step up from the -45.5% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -CA$921K-104.6% QoQ
- Last fiscal yearSep 2025
- -CA$24.76M-45.5% YoY
- LTMMar 2026
- -CA$25.21M-249.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -102.2% | -78.4% | +23.8 pp |
| 1 year | -45.5% | +522.2% | +567.7 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
CAD · from the cash flow
- Latest · FY2025
- (24.76M) CAD
- Year-over-year change
- +45.5%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (24.76M) | +45.5% |
| FY2024 | 2024-09-30 | (45.44M) | +80.2% |
| FY2023 | 2023-09-30 | (229.48M) | -1506.7% |
| FY2022 | 2022-08-31 | (14.28M) | +89.1% |
| FY2021 | 2021-08-31 | (130.7M) | — |
Net Income vs competitors
How OGI.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -249.3% is the 9th highest of 10, against a peer median of -42.7%.
- Net income amounts to 9.2% of revenue for OGI.TO, versus a peer median of 17.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$263.55M CAD | -56.4% | -28.6% | 84.8% | |
| LTM Mar 2026 | CA$50.24M CAD | -418.7% | -39.5% | 15.8% | |
| LTM Mar 2026 | $42.94M USD | +85.5% | +18.4% | — | |
| LTM Mar 2026 | CA$33.21M CAD | +52.5% | — | 20.9% | |
| LTM Mar 2026 | $33.14M USD | -68.8% | +19.7% | 10.9% | |
| LTM Mar 2026 | $31.07M USD | +236.1% | +0.9% | 61.0% | |
| LTM Mar 2026 | CA$25.21M CAD | -249.3% | — | 9.2% | |
| LTM Mar 2026 | $20.19M USD | -71.2% | — | 7.7% | |
| LTM Mar 2026 | $10.31M USD | -42.7% | -19.2% | 18.5% | |
| LTM Mar 2026 | $8.81M USD | -39.0% | -25.7% | 17.2% | |
| Peer median (excluding OGI.TO) | — | -42.7% | -19.2% | 17.9% | |
Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | (130.7M) | (14.28M) | (229.48M) | (45.44M) | (24.76M) |
| Depreciation & Amortization | 31.03M | 24.91M | 24.17M | 12.08M | 17.98M |
| Deferred Income Tax | 42.21M | (88K) | (3.62M) | 0 | (13.77M) |
| Stock-Based Compensation | 3.9M | 5.13M | 5.29M | 7.18M | 4.22M |
| Change in Working Capital | 24.2M | (22.88M) | 12.51M | 14.96M | (2.12M) |
| Accounts Receivables | (6.01M) | (24.02M) | 12.51M | (12.06M) | (15.29M) |
| Inventory | 28.68M | (12.22M) | 0 | 0 | 0 |
| Accounts Payables | 2.06M | 12.15M | 0 | 0 | 0 |
| Other Working Capital | (542K) | 1.21M | (5.52M) | 27.02M | 13.16M |
| Other Non-Cash Items | 776K | (29M) | 155.33M | 15.09M | 12.47M |
| Operating Cash Flow | (28.59M) | (36.21M) | (35.8M) | 3.87M | (7.59M) |
| Capital Expenditures | (12.33M) | (48.78M) | (26.9M) | (5.34M) | (17.05M) |
| Acquisitions (Net) | (2.54M) | (11.06M) | 1.03M | 257K | (65.62M) |
| Purchases of Investments | (120.02M) | (15M) | (10M) | (29.24M) | (1.01M) |
| Sales of Investments | 50.85M | 114.59M | 49.4M | 3.52M | 2.5M |
| Other Investing Activities | (31.08M) | 4.29M | (8.65M) | (7.97M) | (1.52M) |
| Investing Cash Flow | (115.11M) | 44.03M | 1.36M | (38.77M) | (82.67M) |
| Debt Repayment | (116.4M) | (1.01M) | (87K) | (786K) | (60K) |
| Common Stock Issued | 284.88M | 6.34M | 20K | 108.56M | 41.18M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.99M | 6.34M | (750K) | 6K | (1.79M) |
| Financing Cash Flow | 174.46M | 5.33M | (817K) | 107.78M | 39.33M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 313K |
| Net Change in Cash | 30.77M | 13.15M | (34.65M) | 72.88M | (49.01M) |
| Free Cash Flow | (40.92M) | (84.99M) | (62.7M) | (1.47M) | (24.64M) |
OrganiGram Holdings Inc.
TSX:OGI.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.